摘要 |
The invention is directed to methods for treating and/or controlling obes ity in a patient. The methods involve combination therapies using a microsom al triglyceride transfer protein (MTP) inhibitor (for example, AEGR-733 and implitapide) and a cholesterol absorption inhibitor (CAI) (for example, ezet imibe).
|